Vygoris / Substipharm announce the full acquisition of the nystatin based product (ready mixed Oral suspension) across Europe from BMS.
Vygoris announces distribution agreement with Dr Pfleger GmgH in Germany.
Vygoris announces exclusive licensing agreement with Verity Pharmaceuticals to offer a safe and steady supply of Mitomycin in Canada.
Vygoris will launch its first product in the UK in the bladder cancer area. Further information will shortly be available on the Mitocin website.
Vygoris will attend the Swiss HLG Winter Conference 28th – 30th January 2018.